Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth
Advertisement
http://www.reportlinker.com/p0203701/Business-Intelligence-in-the-Pharmaceutical-Market-Growth-drivers-key-organizational-priorities-and-vendor-strategies-for-future-growth.html
Advertisement
The pharmaceutical industry is challenged with information integration and mapping across the various business processes. This information challenge, along with other issues such as weak product development pipelines, growing generics competition, and rising R&D and regulatory compliance costs are compelling pharmaceutical companies to look for alternatives to remain competitive, maintain profit margins, and enhance market share. Implementation of Business Intelligence (BI) enables the business processes to access more accurate and real-time information, with an ultimate goal of increased efficiency and reduced corporate costs.
This report provides an overview of the BI market in the pharmaceutical sector, including its size and growth, followed by the current trends of BI technologies and adoption of BI tools across key pharmaceutical processes. It gives an insight into the various key players in the BI market, analyzing them based on their product offerings and growth strategies. In addition to the BI supply side, this report assesses the state of the BI market from the demand side perspective. Demand side analysis investigates the uptake of BI in the pharmaceutical sector, investments in current BI use, and planned future use.
Key features of this report
Scope of this report
Key Market Issues
Key findings from this report
Key questions answered
Table of Contents
Business Intelligence in the Pharmaceutical Market
Executive summary 10
The Business Intelligence market in the pharmaceutical sector 10
Key processes in the pharmaceutical sector 10
The uptake of Business Intelligence in the pharmaceutical sector 11
The demand side of Business Intelligence in the pharmaceutical sector 12
The Business Intelligence vendor landscape 12
The future of the Business Intelligence market in the pharmaceutical sector 13
Chapter 1 Introduction 16
Introduction 16
Who is this report for? 17
Research methodology 17
Chapter 2 The Business Intelligence market in the pharmaceutical sector 20
Summary 20
Introduction 21
Importance of BI in the pharmaceutical industry 21
BI market in the pharmaceutical industry: size and growth 22
Drivers for BI adoption in the pharmaceutical industry 24
Enabling strategic decision making 25
Enabling identification of latest sales forecasts and trends 25
Increased outsourcing 26
Attaining cost efficiency 26
Challenges for implementing BI in the pharmaceutical industry 26
Current BI trends in the pharmaceutical industry 27
BI moving beyond operational excellence to technical areas 29
Customized service offering by BI vendors 29
Chapter 3 Key processes in the pharmaceutical sector 32
Summary 32
Introduction 32
Pharmaceutical processes 33
Drug discovery 34
Drug development 34
Manufacturing and supply chain 35
Sales and marketing 36
Chapter 4 The uptake of Business Intelligence in the pharmaceutical sector 40
Summary 40
Introduction 40
Business Intelligence uptake 41
Current BI usage 41
Uptake by organization size 42
Uptake by geographies 43
Short-term BI drivers among current users 44
Longer-term BI drivers among current users 45
BI usage forecast 46
BI usage forecast by components 47
BI usage forecast by enterprise functions 47
Planned increases in spending on Business Intelligence 48
Plans to increase usage: case for persuasion 50
Chapter 5 The demand side of Business Intelligence in the pharmaceutical sector 52
Summary 52
Introduction 52
Organizational priorities 52
Cost reduction: which areas to target? 54
Reducing SG&A costs 54
Cost reduction priorities 55
Business Intelligence users - case studies 56
GlaxoSmithKline - management of the clinical trial process and enhancement of drug development 57
Wyeth Pharma - managing sales effectiveness 57
Chapter 6 The Business Intelligence vendor landscape 60
Summary 60
Introduction 61
The mega vendors 62
IBM Business Intelligence: Cognos, SPSS, ILOG, and IBM BAO 63
Company overview 63
Key offerings and verticals 63
Pharmaceutical solutions and major customers 64
Competitors 64
Growth strategies 65
Microsoft Business Intelligence 66
Company overview 66
Key offerings and verticals 67
Pharmaceutical solutions and major customers 68
Competitors 68
Growth strategies 69
Oracle 70
Company overview 70
Key offerings and verticals 70
Pharmaceutical solutions and major customers 71
Competitors 72
Growth strategies 72
SAP BusinessObjects 73
Company overview 73
Key offerings and verticals 73
Pharmaceutical solutions and major customers 75
Competitors 75
Growth strategies 76
Niche vendors 77
Actuate 77
Company overview 77
Key offerings and verticals 78
Pharmaceutical solutions and major customers 78
Competitors 79
Growth strategies 79
Information Builders 80
Company overview 80
Key offerings and verticals 80
Pharmaceutical solutions and major customers 81
Competitors 82
Growth strategies 82
MicroStrategy 82
Company overview 82
Key offerings and verticals 83
Pharmaceutical solutions and major customers 84
Competitors 85
Growth strategies 85
QlikTech 86
Company overview 86
Key offerings and verticals 86
Pharmaceutical solution and major customers 86
Competitors 86
Growth strategies 87
SAS 88
Company overview 88
Key offerings and verticals 88
Pharmaceutical solutions and major customers 89
Competitors 90
Growth strategies 90
TIBCO Spotfire 91
Company overview 91
Key offerings and verticals 91
Pharmaceutical solutions and major customers 92
Competitors 93
Growth strategies 93
Chapter 7 The future of the Business Intelligence market in the pharmaceutical sector 96
Summary 96
Introduction 97
Transition of the pharmaceutical sales and marketing model through predictive analytics 98
Major vendors 99
Shifting to in-memory analytics helps rapid information delivery to the sales force 100
Major vendors 100
Leveraging SaaS for data analytics 101
Major vendors 101
Open source paving its way into SMBs 102
Major vendors 102
Appendix 105
Glossary 105
Index 107
List of Figures
Figure 2.1: BI spending by big pharma in the US and Europe ($m), 2006-2012 23
Figure 2.2: Drivers and challenges for BI implementation in the pharmaceutical industry 24
Figure 2.3: Current BI trends in the pharmaceutical industry 28
Figure 3.4: Pharma-specific typical Business Intelligence solutions 33
Figure 4.5: BI usage by organizations (% respondents, 2010) 41
Figure 4.6: Current BI users by areas of operation (% respondents using BI, 2010) 42
Figure 4.7: BI users by organization size (% respondents, 2010) 43
Figure 4.8: BI users by geography (% respondents, 2010) 44
Figure 4.9: Short-term factors most likely to drive BI uptake among current users 45
Figure 4.10: Longer-term factors likely to drive BI uptake among current users (% respondents) 46
Figure 4.11: Forecast of BI usage by components (% respondents) 47
Figure 4.12: Forecast of BI usage by enterprise functions (% respondents) 48
Figure 4.13: Current user plans to change spending on BI in 2010-2011 49
Figure 4.14: Case for persuasion: current BI user indecisiveness by enterprise functions 50
Figure 5.15: Organizational priorities 53
Figure 5.16: Is reduction of SG&A costs a high priority in 2010? 55
Figure 5.17: Cost reduction priorities by enterprise function 56
Figure 6.18: Business Intelligence vendor landscape 61
Figure 6.19: Summary of the mega vendors 62
Figure 7.20: Spectrum of Business Intelligence technologies 97
List of Tables
Table 3.1: Drug discovery KPIs and BI solutions 34
Table 3.2: Drug development KPIs and BI solutions 35
Table 3.3: Manufacturing and supply chain KPIs and BI solutions 36
Table 3.4: Sales and marketing KPIs and BI solutions 37
Table 6.5: IBM Cognos Business Intelligence offerings 63
Table 6.6: IBM Cognos pharmaceutical solutions 65
Table 6.7: IBM major M&A deals, 2008-2010* 66
Table 6.8: Microsoft Business Intelligence offerings 67
Table 6.9: Microsoft Business Intelligence pharmaceutical solutions 68
Table 6.10: Microsoft Business Intelligence major M&A deals, 2008-2010* 70
Table 6.11: Oracle Business Intelligence offerings 71
Table 6.12: Oracle pharmaceutical solutions 71
Table 6.13: Oracle major M&A deals, 2008-10* 73
Table 6.14: SAP BusinessObjects Business Intelligence offerings 74
Table 6.15: SAP BusinessObjects pharmaceutical solutions 75
Table 6.16: SAP BusinessObjects major M&A deals, 2008-2010* 77
Table 6.17: Actuate Business Intelligence offerings 78
Table 6.18: Actuate pharmaceutical solutions 79
Table 6.19: Actuate major M&A deal, 2008-2010* 80
Table 6.20: Information Builders' Business Intelligence offerings 81
Table 6.21: Information Builders' pharmaceutical solutions 81
Table 6.22: MicroStrategy Business Intelligence offerings 83
Table 6.23: MicroStrategy pharmaceutical solutions 84
Table 6.24: QlikTech pharmaceutical solutions 87
Table 6.25: SAS Business Intelligence offerings 88
Table 6.26: SAS pharmaceutical solutions 89
Table 6.27: SAS major M&A deals, 2008-2010* 91
Table 6.28: TIBCO Spotfire Business Intelligence offerings 92
Table 6.29: TIBCO Spotfire pharmaceutical solutions 92
Table 6.30: TIBCO Spotfire major M&A deal, 2008-2010* 94
To order this report:
Pharmaceutical Industry: Business Intelligence in the Pharmaceutical Market: Growth drivers, key organizational priorities, and vendor strategies for future growth
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
-- Analysis of the BI market in the pharmaceutical sector in terms of size and growth rate. -- Evaluation of the drivers behind the increased spending on BI solutions by Big Pharma companies. -- Key challenges in developing a data warehouse that delivers BI capabilities for the pharmaceutical industry. -- Demand side analysis of the uptake of BI in the pharmaceutical sector, investment in current BI use, and planned future use. -- Insight into the activities, views, and strategies of the major BI vendors.
SOURCE Reportlinker
